{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:18:13Z","timestamp":1715300293523},"reference-count":73,"publisher":"Japanese Society of Toxicology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2022]]},"DOI":"10.2131\/jts.47.337","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T22:10:34Z","timestamp":1659478234000},"page":"337-348","source":"Crossref","is-referenced-by-count":0,"title":["CREB is a potential marker associated with drug-induced liver injury: Identification and validation through transcriptome database analysis"],"prefix":"10.2131","volume":"47","author":[{"given":"Qiyue","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"So","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmaceutics and Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmaceutics and Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Hashida","sequence":"additional","affiliation":[{"name":"Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyoshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University"},{"name":"Department of Applied Pharmaceutics and Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aguilar Mora, F.A., Musheshe, N., Oun, A., Buist-Homan, M., Lezoualc\u2019h, F., Cheng, X., Schmidt, M. and Moshage, H. (2021): Elevated cAMP Protects against Diclofenac-Induced Toxicity in Primary Rat Hepatocytes: A Protective Effect Mediated by the Exchange Protein Directly Activated by cAMP\/cAMP-Regulated Guanine Nucleotide Exchange Factors. Mol. Pharmacol., <b>99<\/b>, 294-307.","DOI":"10.1124\/molpharm.120.000217"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Aleo, M.D., Luo, Y., Swiss, R., Bonin, P.D., Potter, D.M. and Will, Y. (2014): Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology, <b>60<\/b>, 1015-1022.","DOI":"10.1002\/hep.27206"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Ames, B.N., Mccann, J. and Yamasaki, E. (1975): Methods for detecting carcinogens and mutagens with the Salmonella\/mammalian-microsome mutagenicity test. Mutat. Res., <b>31<\/b>, 347-364.","DOI":"10.1016\/0165-1161(75)90046-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Arnesdotter, E., Spinu, N., Firman, J., Ebbrell, D., Cronin, M.T., Vanhaecke, T. and Vinken, M. (2021): Derivation, characterisation and analysis of an adverse outcome pathway network for human hepatotoxicity. Toxicology, <b>459<\/b>, 152856.","DOI":"10.1016\/j.tox.2021.152856"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Attene-Ramos, M.S., Miller, N., Huang, R., Michael, S., Itkin, M., Kavlock, R.J., Austin, C.P., Shinn, P., Simeonov, A., Tice, R.R. and Xia, M. (2013): The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality. Drug Discov. Today, <b>18<\/b>, 716-723.","DOI":"10.1016\/j.drudis.2013.05.015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Bell, L.N. and Chalasani, N. (2009): Epidemiology of idiosyncratic drug-induced liver injury. Semin. Liver Dis., <b>29<\/b>, 337-347.","DOI":"10.1055\/s-0029-1240002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Bellezza, I., Giambanco, I., Minelli, A. and Donato, R. (2018): Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim. Biophys. Acta Mol. Cell Res., <b>1865<\/b>, 721-733.","DOI":"10.1016\/j.bbamcr.2018.02.010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Bhattacharya, D., Azambuja, A.P. and Simoes-Costa, M. (2020): Metabolic Reprogramming Promotes Neural Crest Migration via Yap\/Tead Signaling. Dev. Cell, <b>53<\/b>, 199-211.e6.","DOI":"10.1016\/j.devcel.2020.03.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Boehme, K., Dietz, Y., Hewitt, P. and Mueller, S.O. (2010): Activation of P53 in HepG2 cells as surrogate to detect mutagens and promutagens <i>in vitro.<\/i> Toxicol. Lett., <b>198<\/b>, 272-281.","DOI":"10.1016\/j.toxlet.2010.07.007"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Bragde, H.G., Jansson, U., Fredrikson, M., Grodzinsky, E. and S\u00f6derman, J. (2020): Characterisation of gene and pathway expression in stabilised blood from children with coeliac disease. BMJ Open Gastroenterol., <b>7<\/b>.","DOI":"10.1136\/bmjgast-2020-000536"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Brandon, E.F., Raap, C.D., Meijerman, I., Beijnen, J.H. and Schellens, J.H. (2003): An update on <i>in vitro<\/i> test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol., <b>189<\/b>, 233-246.","DOI":"10.1016\/S0041-008X(03)00128-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Chen, H., Wild, C., Zhou, X., Ye, N., Cheng, X. and Zhou, J. (2014): Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC). J. Med. Chem., <b>57<\/b>, 3651-3665.","DOI":"10.1021\/jm401425e"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Chen, M., Vijay, V., Shi, Q., Liu, Z., Fang, H. and Tong, W. (2011): FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov. Today, <b>16<\/b>, 697-703.","DOI":"10.1016\/j.drudis.2011.05.007"},{"key":"14","doi-asserted-by":"publisher","unstructured":"Chiang, M.C., Cheng, Y.C., Chen, H.M., Liang, Y.J. and Yen, C.H. (2014): Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathway. Mitochondrion, <b>14<\/b>, 7-17.","DOI":"10.1016\/j.mito.2013.12.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Copple, I.M., den Hollander, W., Callegaro, G., Mutter, F.E., Maggs, J.L., Schofield, A.L., Rainbow, L., Fang, Y., Sutherland, J.J., Ellis, E.C., Ingelman-Sundberg, M., Fenwick, S.W., Goldring, C.E., van de Water, B., Stevens, J.L. and Park, B.K. (2019): Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury. Arch. Toxicol., <b>93<\/b>, 385-399.","DOI":"10.1007\/s00204-018-2354-1"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Copple, I.M., Goldring, C.E., Jenkins, R.E., Chia, A.J., Randle, L.E., Hayes, J.D., Kitteringham, N.R. and Park, B.K. (2008): The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system. Hepatology, <b>48<\/b>, 1292-1301.","DOI":"10.1002\/hep.22472"},{"key":"17","unstructured":"David, S. and Hamilton, J.P. (2010): Drug-induced Liver Injury. US Gastroenterol. Hepatol. Rev., <b>6<\/b>, 73-80."},{"key":"18","doi-asserted-by":"crossref","unstructured":"De Cesare, D., Fimia, G.M. and Sassone-Corsi, P. (1999): Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem. Sci., <b>24<\/b>, 281-285.","DOI":"10.1016\/S0968-0004(99)01414-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Donato, M.T., Lahoz, A., Castell, J.V. and G\u00f3mez-Lech\u00f3n, M.J. (2008): Cell lines: a tool for <i>in vitro<\/i> drug metabolism studies. Curr. Drug Metab., <b>9<\/b>, 1-11.","DOI":"10.2174\/138920008783331086"},{"key":"20","doi-asserted-by":"crossref","unstructured":"El-Kholy, A.A., Elkablawy, M.A. and El-Agamy, D.S. (2017): Lutein mitigates cyclophosphamide induced lung and liver injury via NF-\u03baB\/MAPK dependent mechanism. Biomed. Pharmacother., <b>92<\/b>, 519-527.","DOI":"10.1016\/j.biopha.2017.05.103"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Fan, F. and Wood, K.V. (2007): Bioluminescent assays for high-throughput screening. Assay Drug Dev. Technol., <b>5<\/b>, 127-136.","DOI":"10.1089\/adt.2006.053"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Fasinu, P., Bouic, P.J. and Rosenkranz, B. (2012): Liver-based <i>in vitro<\/i> technologies for drug biotransformation studies - a review. Curr. Drug Metab., <b>13<\/b>, 215-224.","DOI":"10.2174\/138920012798918426"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Feng, S. and He, X. (2013): Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity. Curr. Drug Metab., <b>14<\/b>, 921-945.","DOI":"10.2174\/138920021131400114"},{"key":"24","doi-asserted-by":"publisher","unstructured":"Ferretti, A.C., Mattaloni, S.M., Ochoa, J.E., Larocca, M.C. and Favre, C. (2012): Protein kinase A signals apoptotic activation in glucose-deprived hepatocytes: participation of reactive oxygen species. Apoptosis, <b>17<\/b>, 475-491.","DOI":"10.1007\/s10495-012-0697-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Fujimoto, K., Kishino, H., Yamoto, T., Manabe, S. and Sanbuissho, A. (2010): In vitro cytotoxicity assay to evaluate the toxicity of an electrophilic reactive metabolite using glutathione-depleted rat primary cultured hepatocytes. Chem. Biol. Interact., <b>188<\/b>, 404-411.","DOI":"10.1016\/j.cbi.2010.09.012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Ganter, B., Tugendreich, S., Pearson, C.I., Ayanoglu, E., Baumhueter, S., Bostian, K.A., Brady, L., Browne, L.J., Calvin, J.T., Day, G.J., Breckenridge, N., Dunlea, S., Eynon, B.P., Furness, L.M., Ferng, J., Fielden, M.R., Fujimoto, S.Y., Gong, L., Hu, C., Idury, R., Judo, M.S., Kolaja, K.L., Lee, M.D., McSorley, C., Minor, J.M., Nair, R.V., Natsoulis, G., Nguyen, P., Nicholson, S.M., Pham, H., Roter, A.H., Sun, D., Tan, S., Thode, S., Tolley, A.M., Vladimirova, A., Yang, J., Zhou, Z. and Jarnagin, K. (2005): Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J. Biotechnol., <b>119<\/b>, 219-244.","DOI":"10.1016\/j.jbiotec.2005.03.022"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Gao, W., Mizukawa, Y., Nakatsu, N., Minowa, Y., Yamada, H., Ohno, Y. and Urushidani, T. (2010): Mechanism-based biomarker gene sets for glutathione depletion-related hepatotoxicity in rats. Toxicol. Appl. Pharmacol., <b>247<\/b>, 211-221.","DOI":"10.1016\/j.taap.2010.06.015"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Garg, S.S., Gupta, J., Sharma, S. and Sahu, D. (2020): An insight into the therapeutic applications of coumarin compounds and their mechanisms of action. Eur. J. Pharm. Sci., <b>152<\/b>, 105424.","DOI":"10.1016\/j.ejps.2020.105424"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Gautier, L., Cope, L., Bolstad, B.M. and Irizarry, R.A. (2004): affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, <b>20<\/b>, 307-315.","DOI":"10.1093\/bioinformatics\/btg405"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Glas, E., M\u00fcckter, H., Gudermann, T. and Breit, A. (2016): Exchange factors directly activated by cAMP mediate melanocortin 4 receptor-induced gene expression. Sci. Rep., <b>6<\/b>, 32776.","DOI":"10.1038\/srep32776"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Hassanein, E.H., Sayed, A.M., Hussein, O.E. and Mahmoud, A.M. (2020): Coumarins as Modulators of the Keap1\/Nrf2\/ARE Signaling Pathway. Oxid. Med. Cell. Longev., <b>2020<\/b>, 1675957.","DOI":"10.1155\/2020\/1675957"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Hasselblatt, P., Rath, M., Komnenovic, V., Zatloukal, K. and Wagner, E.F. (2007): Hepatocyte survival in acute hepatitis is due to c-Jun\/AP-1-dependent expression of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA, <b>104<\/b>, 17105-17110.","DOI":"10.1073\/pnas.0706272104"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Igarashi, Y., Nakatsu, N., Yamashita, T., Ono, A., Ohno, Y., Urushidani, T. and Yamada, H. (2015): Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res., <b>43<\/b>, D921-D927.","DOI":"10.1093\/nar\/gku955"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Itoh, K., Ishii, T., Wakabayashi, N. and Yamamoto, M. (1999): Regulatory mechanisms of cellular response to oxidative stress. Free Radic. Res., <b>31<\/b>, 319-324.","DOI":"10.1080\/10715769900300881"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Jain, A., Lamark, T., Sj\u00f8ttem, E., Larsen, K.B., Awuh, J.A., \u00d8vervatn, A., McMahon, M., Hayes, J.D. and Johansen, T. (2010): p62\/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem., <b>285<\/b>, 22576-22591.","DOI":"10.1074\/jbc.M110.118976"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Katarey, D. and Verma, S. (2016): Drug-induced liver injury. Clin. Med. (Lond.), <b>16<\/b> (Suppl 6), s104-s109.","DOI":"10.7861\/clinmedicine.16-6-s104"},{"key":"37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hep.23317","author":"C. Lammert","year":"2010","unstructured":"Lammert, C., Bjornsson, E., Niklasson, A. and Chalasani, N. (2010): Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology, <b>51<\/b>, 615-620.","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Lee, C. (2017): Collaborative Power of Nrf2 and PPAR<i>\u03b3<\/i> Activators against Metabolic and Drug-Induced Oxidative Injury. Oxid. Med. Cell. Longev., <b>2017<\/b>, 1378175.","DOI":"10.1155\/2017\/1378175"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Lee, W.M. (2003): Drug-induced hepatotoxicity. N. Engl. J. Med., <b>349<\/b>, 474-485.","DOI":"10.1056\/NEJMra021844"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Liu, Z., Huang, R., Roberts, R. and Tong, W. (2019): Toxicogenomics: A 2020 Vision. Trends Pharmacol. Sci., <b>40<\/b>, 92-103.","DOI":"10.1016\/j.tips.2018.12.001"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Low, Y., Uehara, T., Minowa, Y., Yamada, H., Ohno, Y., Urushidani, T., Sedykh, A., Muratov, E., Kuz\u2019min, V., Fourches, D., Zhu, H., Rusyn, I. and Tropsha, A. (2011): Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches. Chem. Res. Toxicol., <b>24<\/b>, 1251-1262.","DOI":"10.1021\/tx200148a"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Ma, Q. (2013): Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol., <b>53<\/b>, 401-426.","DOI":"10.1146\/annurev-pharmtox-011112-140320"},{"key":"43","doi-asserted-by":"crossref","unstructured":"M\u00e4kel\u00e4, J., Tselykh, T.V., Kukkonen, J.P., Eriksson, O., Korhonen, L.T. and Lindholm, D. (2016): Peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3) agonist is neuroprotective and stimulates PGC-1\u03b1 expression and CREB phosphorylation in human dopaminergic neurons. Neuropharmacology, <b>102<\/b>, 266-275.","DOI":"10.1016\/j.neuropharm.2015.11.020"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Malhotra, D., Portales-Casamar, E., Singh, A., Srivastava, S., Arenillas, D., Happel, C., Shyr, C., Wakabayashi, N., Kensler, T.W., Wasserman, W.W. and Biswal, S. (2010): Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res., <b>38<\/b>, 5718-5734.","DOI":"10.1093\/nar\/gkq212"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Mathur, R., Rotroff, D., Ma, J., Shojaie, A. and Motsinger-Reif, A. (2018): Gene set analysis methods: a systematic comparison. BioData Min., <b>11<\/b>, 8.","DOI":"10.1186\/s13040-018-0166-8"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Merrick, B.A. (2019): Next generation sequencing data for use in risk assessment. Curr. Opin. Toxicol., <b>18<\/b>, 18-26.","DOI":"10.1016\/j.cotox.2019.02.010"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Murakami, S. and Motohashi, H. (2015): Roles of Nrf2 in cell proliferation and differentiation. Free Radic. Biol. Med., <b>88<\/b> (Pt B), 168-178.","DOI":"10.1016\/j.freeradbiomed.2015.06.030"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Nakayama, S., Atsumi, R., Takakusa, H., Kobayashi, Y., Kurihara, A., Nagai, Y., Nakai, D. and Okazaki, O. (2009): A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding. Drug Metab. Dispos., <b>37<\/b>, 1970-1977.","DOI":"10.1124\/dmd.109.027797"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B. and Heller, A. (2000): Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol., <b>32<\/b>, 56-67.","DOI":"10.1006\/rtph.2000.1399"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Otto, M., Hansen, S.H., Dalgaard, L., Dubois, J. and Badolo, L. (2008): Development of an <i>in vitro<\/i> assay for the investigation of metabolism-induced drug hepatotoxicity. Cell Biol. Toxicol., <b>24<\/b>, 87-99.","DOI":"10.1007\/s10565-007-9018-x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Ramos-Alvarez, I., Lee, L. and Jensen, R.T. (2019): Cyclic AMP-dependent protein kinase A and EPAC mediate VIP and secretin stimulation of PAK4 and activation of Na<sup>+<\/sup>,K<sup>+<\/sup>-ATPase in pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol., <b>316<\/b>, G263-G277.","DOI":"10.1152\/ajpgi.00275.2018"},{"key":"52","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Antona, C., Donato, M.T., Boobis, A., Edwards, R.J., Watts, P.S., Castell, J.V. and G\u00f3mez-Lech\u00f3n, M.J. (2002): Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica, <b>32<\/b>, 505-520.","DOI":"10.1080\/00498250210128675"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Rui, L. (2014): Energy metabolism in the liver. Compr. Physiol., <b>4<\/b>, 177-197.","DOI":"10.1002\/cphy.c130024"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Schenborn, E. and Groskreutz, D. (1999): Reporter gene vectors and assays. Mol. Biotechnol., <b>13<\/b>, 29-44.","DOI":"10.1385\/MB:13:1:29"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Servillo, G., Della Fazia, M.A. and Sassone-Corsi, P. (2002): Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM. Exp. Cell Res., <b>275<\/b>, 143-154.","DOI":"10.1006\/excr.2002.5491"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Shah, F., Leung, L., Barton, H.A., Will, Y., Rodrigues, A.D., Greene, N. and Aleo, M.D. (2015): Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic <i>in vitro<\/i> Assays. Toxicol. Sci., <b>147<\/b>, 500-514.","DOI":"10.1093\/toxsci\/kfv152"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Shaywitz, A.J. and Greenberg, M.E. (1999): CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem., <b>68<\/b>, 821-861.","DOI":"10.1146\/annurev.biochem.68.1.821"},{"key":"58","doi-asserted-by":"publisher","unstructured":"Stravitz, R.T. and Lee, W.M. (2019): Acute liver failure. Lancet, <b>394<\/b>, 869-881.","DOI":"10.1016\/S0140-6736(19)31894-X"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S. and Mesirov, J.P. (2005): Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA, <b>102<\/b>, 15545-15550.","DOI":"10.1073\/pnas.0506580102"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Suter, L., Schroeder, S., Meyer, K., Gautier, J.C., Amberg, A., Wendt, M., Gmuender, H., Mally, A., Boitier, E., Ellinger-Ziegelbauer, H., Matheis, K. and Pfannkuch, F. (2011): EU framework 6 project: predictive toxicology (PredTox)--overview and outcome. Toxicol. Appl. Pharmacol., <b>252<\/b>, 73-84.","DOI":"10.1016\/j.taap.2010.10.008"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Taguchi, K. and Kensler, T.W. (2020): Nrf2 in liver toxicology. Arch. Pharm. Res., <b>43<\/b>, 337-349.","DOI":"10.1007\/s12272-019-01192-3"},{"key":"62","doi-asserted-by":"publisher","unstructured":"Temple, R.J. and Himmel, M.H. (2002): Safety of newly approved drugs: implications for prescribing. JAMA, <b>287<\/b>, 2273-2275.","DOI":"10.1001\/jama.287.17.2273"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Than, T.A., Lou, H., Ji, C., Win, S. and Kaplowitz, N. (2011): Role of cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 3 (CRTC3) in the initiation of mitochondrial biogenesis and stress response in liver cells. J. Biol. Chem., <b>286<\/b>, 22047-22054.","DOI":"10.1074\/jbc.M111.240481"},{"key":"64","doi-asserted-by":"crossref","unstructured":"Urban, T.J., Shen, Y., Stolz, A., Chalasani, N., Fontana, R.J., Rochon, J., Ge, D., Shianna, K.V., Daly, A.K., Lucena, M.I., Nelson, M.R., Molokhia, M., Aithal, G.P., Floratos, A., Pe\u2019er, I., Serrano, J., Bonkovsky, H., Davern, T.J., Lee, W.M., Navarro, V.J., Talwalkar, J.A., Goldstein, D.B. and Watkins, P.B.; Drug-Induced Liver Injury Network; DILIGEN; EUDRAGENE; Spanish DILI Registry; International Serious Adverse Events Consortium. (2012): Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet. Genomics, <b>22<\/b>, 784-795.","DOI":"10.1097\/FPC.0b013e3283589a76"},{"key":"65","doi-asserted-by":"publisher","unstructured":"Verma, S. and Kaplowitz, N. (2009): Diagnosis, management and prevention of drug-induced liver injury. Gut, <b>58<\/b>, 1555-1564.","DOI":"10.1136\/gut.2008.163675"},{"key":"66","doi-asserted-by":"crossref","unstructured":"Wang, S., Wang, M., Wang, M., Tian, Y., Sun, X., Sun, G. and Sun, X. (2018): Bavachinin Induces Oxidative Damage in HepaRG Cells through p38\/JNK MAPK Pathways. Toxins (Basel), <b>10<\/b>.","DOI":"10.3390\/toxins10040154"},{"key":"67","doi-asserted-by":"crossref","unstructured":"Westerink, W.M. and Schoonen, W.G. (2007): Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. In Vitro, <b>21<\/b>, 1581-1591.","DOI":"10.1016\/j.tiv.2007.05.014"},{"key":"68","doi-asserted-by":"publisher","unstructured":"Xie, W., Barwick, J.L., Downes, M., Blumberg, B., Simon, C.M., Nelson, M.C., Neuschwander-Tetri, B.A., Brunt, E.M., Guzelian, P.S. and Evans, R.M. (2000a): Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature, <b>406<\/b>, 435-439.","DOI":"10.1038\/35019116"},{"key":"69","doi-asserted-by":"crossref","unstructured":"Xie, W., Barwick, J.L., Simon, C.M., Pierce, A.M., Safe, S., Blumberg, B., Guzelian, P.S. and Evans, R.M. (2000b): Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR. Genes Dev., <b>14<\/b>, 3014-3023.","DOI":"10.1101\/gad.846800"},{"key":"70","doi-asserted-by":"crossref","unstructured":"Xu, W., Hellerbrand, C., K\u00f6hler, U.A., Bugnon, P., Kan, Y.W., Werner, S. and Beyer, T.A. (2008): The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis. Lab. Invest., <b>88<\/b>, 1068-1078.","DOI":"10.1038\/labinvest.2008.75"},{"key":"71","doi-asserted-by":"crossref","unstructured":"Yuan, L. and Kaplowitz, N. (2013): Mechanisms of drug-induced liver injury. Clin. Liver Dis., <b>17<\/b>, 507-518. vii.","DOI":"10.1016\/j.cld.2013.07.002"},{"key":"72","doi-asserted-by":"crossref","unstructured":"Yun, J.W., Kim, M., Cho, S.D., Lee, J.Y., Bae, O.N. and Lim, K.M. (2014): Highly expressed protein kinase A inhibitor \u03b1 and suppression of protein kinase A may potentiate acetaminophen-induced hepatotoxicity. Toxicol. Lett., <b>229<\/b>, 59-65.","DOI":"10.1016\/j.toxlet.2014.06.010"},{"key":"73","doi-asserted-by":"crossref","unstructured":"Zhu, W., Jia, Q., Wang, Y., Zhang, Y. and Xia, M. (2012): The anthocyanin cyanidin-3-O-\u03b2-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: involvement of a cAMP-PKA-dependent signaling pathway. Free Radic. Biol. Med., <b>52<\/b>, 314-327.","DOI":"10.1016\/j.freeradbiomed.2011.10.483"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/8\/47_337\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T04:57:14Z","timestamp":1715230634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/8\/47_337\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.47.337","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}